Meena Subramanyam

Meena Subramanyam

Takeda Pharmaceutical Company Limited - Osaka / Japan
Medical and Health Sciences / Gastroenterology
AD Scientific Index ID: 4406150
武田薬品工業株式会社
person_outline Meena Subramanyam's MOST POPULAR ARTICLES
1-) Risk of natalizumab-associated progressive multifocal leukoencephalopathyG Bloomgren, S Richman, C Hotermans, M Subramanyam, S Goelz, ...New England Journal of Medicine 366 (20), 1870-1880, 201212982012
2-) Anti‐JC virus antibodies: implications for PML risk stratificationL Gorelik, M Lerner, S Bixler, M Crossman, B Schlain, K Simon, A Pace, ...Annals of neurology 68 (3), 295-303, 20105052010
3-) Anti–JC virus antibody levels in serum or plasma further define risk of natalizumab‐associated progressive multifocal leukoencephalopathyT Plavina, M Subramanyam, G Bloomgren, S Richman, A Pace, S Lee, ...Annals of neurology 76 (6), 802-812, 20144302014
4-) Assessment and reporting of the clinical immunogenicity of therapeutic proteins and peptides—harmonized terminology and tactical recommendationsG Shankar, S Arkin, L Cocea, V Devanarayan, S Kirshner, A Kromminga, ...The AAPS journal 16, 658-673, 20143082014
5-) Challenges and approaches for the development of safer immunomodulatory biologicsJG Sathish, S Sethu, MC Bielsky, L De Haan, NS French, K Govindappa, ...Nature Reviews Drug Discovery 12 (4), 306-324, 20131932013